The amygdala is important in regulation of emotion-associated behavioral responses both to positive reinforcing stimuli such as addicting opioids and to negative aversive stimuli such as fear and pain. Glutamatergic neurotransmission in amygdala plays a predominant role in amygdala neuronal circuits involved in these emotional responses. However, how specific glutamate receptors act to mediate these amygdala functions remains poorly understood. In this study, we investigated the role of GluA1 subunits of glutamate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in central amygdala in modulating behavioral response to aversive stimuli by pain and by opioid withdrawal. We found that the protein level of GluA1 in the central nucleus of amygdala (CeA) was significantly increased in rats under persistent pain and viral upregulation of CeA GluA1 increased pain responses of both hyperalgesia and allodynia in rats. In contrast, the viral upregulation of CeA GluA1 inhibited, while knockdown of CeA GluA1 enhanced, place aversion induced by naloxone-precipitated morphine withdrawal. These results reveal a differential action of CeA GluA1 on the aversive event of sensory pain and opioid withdrawal, likely reflecting two distinct synaptic circuits of GluA1-predominant AMPA receptors within CeA for regulation of pain sensitivity and emotional response to opioid withdrawal.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068745 | PMC |
| http://dx.doi.org/10.1177/1744806920911543 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
GluA1 in central amygdala increases pain but inhibits opioid withdrawal-induced aversion.
Mol Pain
February 2021
Department of Anesthesiology and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The amygdala is important in regulation of emotion-associated behavioral responses both to positive reinforcing stimuli such as addicting opioids and to negative aversive stimuli such as fear and pain. Glutamatergic neurotransmission in amygdala plays a predominant role in amygdala neuronal circuits involved in these emotional responses. However, how specific glutamate receptors act to mediate these amygdala functions remains poorly understood.
View Article and Find Full Text PDFDifferential Membrane Binding and Seeding of Distinct α-Synuclein Fibrillar Polymorphs.
Biophys J
March 2020
CEA, Institut François Jacob (MIRcen) and CNRS, Laboratory of Neurodegenerative Diseases, Fontenay-aux-Roses, France. Electronic address:
The aggregation of the protein α-synuclein (α-Syn) leads to different synucleinopathies. We recently showed that structurally distinct fibrillar α-Syn polymorphs trigger either Parkinson's disease or multiple system atrophy hallmarks in vivo. Here, we establish a structural-molecular basis for these observations.
View Article and Find Full Text PDFGluA1 in Central Amygdala Promotes Opioid Use and Reverses Inhibitory Effect of Pain.
Neuroscience
February 2020
Department of Anesthesiology and Pain Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:
Increasing evidence suggests that long-term opioids and pain induce similar adaptive changes in the brain's reward circuits, however, how pain alters the addictive properties of opioids remains poorly understood. In this study using a rat model of morphine self-administration (MSA), we found that short-term pain, induced by an intraplantar injection of complete Freund's adjuvant (CFA), acutely decreased voluntary morphine intake, but not food intake, only at a morphine dose that did not affect pain itself. Pre-treatment with indomethacin, a non-opioid inhibitor of pain, before the pain induction blocked the decrease in morphine intake.
View Article and Find Full Text PDFL-Serine dietary supplementation is associated with clinical improvement of loss-of-function -related pediatric encephalopathy.
Sci Signal
June 2019
Bellvitge Biomedical Research Institute (IDIBELL)-Unit of Neuropharmacology and Pain, University of Barcelona, Barcelona 08908, Spain.
Autosomal dominant mutations in are associated with severe encephalopathy, but little is known about the pathophysiological outcomes and any potential therapeutic interventions. Genetic studies have described the association between de novo mutations of genes encoding the subunits of the -methyl-d-aspartate receptor (NMDAR) and severe neurological conditions. Here, we evaluated a missense mutation in , causing a proline-to-threonine switch (P553T) in the GluN2B subunit of NMDAR, which was found in a 5-year-old patient with Rett-like syndrome with severe encephalopathy.
View Article and Find Full Text PDFInsulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior.
Proc Natl Acad Sci U S A
March 2019
Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, MA 02215;
Previous studies have shown that insulin and IGF-1 signaling in the brain, especially the hypothalamus, is important for regulation of systemic metabolism. Here, we develop mice in which we have specifically inactivated both insulin receptors (IRs) and IGF-1 receptors (IGF1Rs) in the hippocampus (Hippo-DKO) or central amygdala (CeA-DKO) by stereotaxic delivery of AAV-Cre into IR/IGF1R mice. Consequently, both Hippo-DKO and CeA-DKO mice have decreased levels of the GluA1 subunit of glutamate AMPA receptor and display increased anxiety-like behavior, impaired cognition, and metabolic abnormalities, including glucose intolerance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!